The approval is indicated for individuals 16 years of age and older, however the vaccine remains available to those aged 12 years and older under the EUA.
All articles by Steve Duffy
The Company expects to start Phase 3 studies for ATTR cardiomyopathy and polyneuropathy in the first half of 2019.
Esmolol Hydrochloride in Sodium Chloride Injection 2500mg/250 mL (10mg/mL) Single-Dose Plastic Bag and 2000mg/100mL (20mg/mL) Single-Dose Plastic Bag, a generic version of Brevibloc (Baxter) now available from Mylan.
The Company is currently enrolling patients in a randomized, double-blind, placebo-controlled Phase 2 trial; they expect to enroll 175 in total.
The risk of angioedema is likely comparable between aliskiren and beta blockers.
Latest News Your top articles for SundayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses